Altium Capital Management »

Apellis Pharmaceuticals Inc put shares owned by Altium Capital Management

Quarter-by-quarter ownership of Apellis Pharmaceuticals Inc put shares owned by Altium Capital Management from 13F filings

Historical chart of Altium Capital Management investment in Apellis Pharmaceuticals Inc put

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals Inc put held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals Inc put by Altium Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.8M 100k 38.04

More positions owned by Altium Capital Management

Cymabay Therapeutics
Immunovant Put Put Option
ImmunoGen
Astria Therapeutics (ATXS)
Xtant Med Hldgs Com New (XTNT)
Amylyx Pharmaceuticals (AMLX)
Adma Biologics (ADMA)
Alimera Sciences Com New (ALIM)
Structure Therapeutics Sponsored Ads (GPCR)
Crinetics Pharmaceuticals In (CRNX)
Xenon Pharmaceuticals (XENE)
Biohaven (BHVN)
Axsome Therapeutics (AXSM)
Karuna Therapeutics Ord
Moonlake Immunotherapeutics Class A Ord (MLTX)

View all positions for Altium Capital Management

Top funds holding Apellis Pharmaceuticals Inc put

Jane Street
Simplex Trading
Jpmorgan Chase & Co

View all funds holding Apellis Pharmaceuticals Inc put